Form 4 for RMD ResMed|
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-11 · accession 0001127602-21-029097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-15 | 2021-11-11 | RMD | PENDARVIS DAVID | Chief Administrative Off | G - Gift | $0.00 | -10.0K | 110.5K | -8% | $0 |
| D | 2021-11-15 | 2021-11-11 | RMD | PENDARVIS DAVID | Chief Administrative Off | M - OptEx | $101.64 | +983 | 120.5K | +0.8% | +$99.9K |
| D | 2021-11-15 | 2021-11-11 | RMD | PENDARVIS DAVID | Chief Administrative Off | F - Tax | $259.47 | -1,549 | 119.5K | -1% | -$401.9K |
| D | 2021-11-15 | 2021-11-11 | RMD | PENDARVIS DAVID | Chief Administrative Off | M - OptEx | $0.00 | -983 | 18.5K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-11-11 | G | D | 10,000 | $0.00 | 110,485 | D | — | — | (F3) Includes 64.3996 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan. |
| 2 | Common | ResMed Common Stock | 2021-11-11 | M | A | 983 | $101.64 | 120,485 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2021-11-11 | F | D | 1,549 | $259.47 | 119,502 | D | — | — | |
| 4 | Derivative | ResMed Common Stock Options | 2021-11-11 | M | D | 983 | $0.00 | 18,468 | D | $101.64 · 2019-11-11 to 2025-11-14 | 983 ResMed Common Stock | (F4) Represents date options first became exercisable. Options vest 1/3 per year. |